Rubenstein slams Higgs report as ‘irrelevant'
UK - Former NAPF investment committee chairman Alan Rubenstein launched a blistering attack on the Higgs report and dismissed it as "irrelevant".
During a debate at the NAPF’s annual conference in Glasgow on the potential impact the Higgs report will have on corporate governance, if any, Rubenstein warned that hostility in boardrooms towards the Higgs proposals means many companies will simply choose to ignore it.
Rubenstein pointed to CBI research which shows 82% of FTSE100 chairman believe that Higgs will undermine their ability to run an effective unified board. And he said that the report’s effectiveness has already been undermined by the fact that one of its key proposals – that chairmen should not head nominations committees – has been withdrawn.
He stressed that the only way good corporate governance could be implemented is if investors take action like they did against pharmaceuticals giant GlaxoSmithKline: “Unless the government and institutions are prepared to force through change, the Higgs proposals will inevitably be watered down until they are irrelevant.
Hermes Focus Asset Management director of institutional relations Michelle Edkins defended the report: “Higgs will help make boards better. All of these subtle changes will produce real improvements. Change will come, it’ll be subtle, gradual and substantial.”
Latest stories
How Next Gen is 'changing the game' for pensions
The Next Generation Pensions Committee is on a mission to promote and encourage younger voices in the industry. Kim Kaveh looks at its key objectives
Five stories you may have missed this week
This week's top stories included an analysis finding the cost of equalising guaranteed minimum pensions in schemes could hit FTSE 100 profits by up to £15bn.
TPR will not set firm ratio for dividends and DRCs
Employers whose dividend to deficit recovery contribution (DRCs) ratios fall outside the "normal range" should expect to see higher regulatory scrutiny, although no fixed ratio will be set.
Final CMA decision likely by Christmas; remedies enforced from June 2019
Investment consultants and fiduciary managers should expect a final decision on the investigation into the market to be published by the end of the year, the competition watchdog says.
